Journal profile · ONCOLOGY
Indian Journal of Surgical Oncology
ISSN 0975-7651 · eISSN 0976-6952 · Springer Nature · 4 issues per year
Indian Journal of Surgical Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.7 (journal website); hybrid open access; APC about USD 3,990; median 108 days to acceptance (101 articles, last 24 months); 324 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Indian Journal of Surgical Oncology is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Breast Cancer Treatment Studies and Head and Neck Cancer Studies, together about 22.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Vision The Indian Journal of Surgical Oncology (IJSO) is an official publication of the Indian Association of Surgical Oncology. IJSO is a leading international platform for original, translational and clinical research, scholarly reviews, and expert opinions in the field of Surgical Oncology. Animal research and pre-clinical studies are outside the scope of IJSO and are usually not considered for publication. This peer reviewed Journal is published bimonthly (January-February, March-April, May-June, July-August, September-October, November-December). Mission The mission of the journal is to (a) disseminate high-quality clinical and translational cancer research, as well as review and expert opinion/commentary/editorial articles; (b) represent the advances in the field of Surgical Oncology globally; (c) promote high-standard multidisciplinary patient care across the world; (d) enhance cancer surgery education and training on an international level; and (e) create diversity in all its initiatives. Audience Surgeons, physicians, scientists, health care professionals and patient advocates who have a major professional interest and commitment to oncology.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief S P SomashekharPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named India 43, United States 8, United Kingdom 4, South Korea 2, Germany 2 (67 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine8.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology8.1%
- Head and Neck Cancer StudiesMedicine5.5%
- Gastric Cancer Management and OutcomesMedicine5.4%
- Breast Lesions and CarcinomasMedicine5.3%
- Ovarian cancer diagnosis and treatmentMedicine5.2%
- Intraperitoneal and Appendiceal MalignanciesMedicine4.9%
- Colorectal Cancer Surgical TreatmentsMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 1Publisher website ·
- CiteScore 2026-06
- 1.3LetPub ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.59LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 369OpenAlex ·
- 2-year mean citedness
- 0.72OpenAlex ·
- Self-citation rate
- 28.6%LetPub ·
- Share of gold OA articles
- 7.21%LetPub ·
Volume
- Articles per year
- 290LetPub ·
- Downloads per year (publisher) 2025
- 224,600Publisher website ·
Articles by year OpenAlex count · 2,674 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 208 | 75 | 14 |
| 2025 | 324 | 255 | 197 |
| 2024 | 298 | 289 | 384 |
| 2023 | 176 | 176 | 340 |
| 2022 | 207 | 206 | 881 |
| 2021 | 221 | 221 | 1,128 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
108 daysMedian, submission to acceptance · P25–P75 62 days – 142 days
- Acceptance to online
- median 14 days (101 articles)
- Submission to online
- median 131 days
- Sample
- 101 articles with submission and acceptance dates (610 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 14 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,990 / EUR 2,990 / GBP 2,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
- Not considered
- Animal research and pre-clinical studies; Narrative reviews
Article types accepted11, with length limits
- case reportCase ReportLength not stated
- commentaryCommentaryLength not stated
- editorialOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…main text ≤ 1,500 words
- letterLetterLength not stated
- letters to the editorDescription: Letters should provide perspectives on articles published in IJSO or on topics of interest to its readership. Letters commenting on previously publ…main text ≤ 500 words
- narrative reviewOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…Length not stated
- originalOriginalLength not stated
- original articleOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…main text ≤ 3,000 words
- reviewOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…Length not stated
- review articleOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…Length not stated
- systematic reviewOriginal article Description: Manuscripts will be considered on all clinical and translational aspects of surgical oncology and related subjects. The manuscript…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, Open access, Peer review, Trial registration / reporting guidelines
- AI use Use of Artificial Intelligence (AI) and Large Language Models (LLM)
No large language models (LLM) tool will be accepted as a credited author on a research paper. This is because any attribution of authorship carries with it accountability for the work and AI tools cannot take such responsibility. Manuscript content as well as images created or recreated by LLMs must be integral to the paper's research design or methods. If such content is included in these rare i…
Source ↗Publisher website ·- Authorship Authorship
All authors must have made substantive intellectual contribution to the article for which they are listed on the byline. The four criteria for authorship defined by the International Committee of Medical Journal Editors are: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; andDrafting the work or revising it cr…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Indian Journal of Surgical Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Double-blind peer review
This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as …
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 0975-7651
- Electronic ISSN
- 0976-6952
- Society / sponsor
- Indian Association of Surgical Oncology
- Latest issue on the website
- Volume 17, Issue 8 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Indian Journal of Surgical Oncology
What CAS zone is Indian Journal of Surgical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Surgical Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Indian Journal of Surgical Oncology?
The journal's website gives an impact factor of 0.7 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.3, h-index 37.
How long does peer review take at Indian Journal of Surgical Oncology?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 62–142 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Indian Journal of Surgical Oncology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Indian Journal of Surgical Oncology based?
Of the 67 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are India (43), United States (8) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Indian Journal of Surgical Oncology?
According to LetPub and DOAJ records, Indian Journal of Surgical Oncology is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Indian Journal of Surgical Oncology open access, and what is the APC?
Indian Journal of Surgical Oncology is a hybrid journal. For open-access publication: APC about USD 3,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .